CURRICULUM VITAE PROF ANDREA FRUSTACI
DATI ANAGRAFICI
Nome:
Andrea Frustaci
Cittadinanza:
Italiana
Indirizzo
Laboratori di Cardiologia Cellulare e Molecolare
INMI L. Spallanzani IRCCS Via Portuense, 292
C.A.P. 00149 Roma
Tel
06.55170520
E-mail
[email protected]
TITOLI DI STUDIO E FORMAZIONE UNIVERSITARIA
1971
Diploma di maturità classica, Roma.
1977
Laurea in Medicina e Chirurgia (110/110 cum Laude),
Università Cattolica del Sacro Cuore, Roma.
1980
Specializzazione in Cardiologia, Università Cattolica del
Sacro Cuore, Roma.
CURRICULUM ACCADEMICO
1982
Research Fellowship presso il King's College Hospital
(Dr. P. Richardson) doce ha appreso la tecnica della
biopsia endomiocardica
1983-1991
Research Fellowship presso il National Heart Hospital
(Dr. E.G.J. Olsen) ed il Brompton Hospital di Londra
dove ha appreso l‟nterpretazione istopatologica delle
biopsie endomiocardiche
1983-2005
Ricercatore Universitario in Cardiologia (settore
scientifico disciplinare MED/11) presso nella Facoltà di
Medicina e Chirugia-Policlinico "A. Gemelli"
2000-2006
“Visiting Associate Professor of Medicine” presso il New
York Medical College (New York- USA).
2004
Idoneità per professore associato in Cardiologia
Marzo 2005
Professore associato presso l‟Università la Sapienza di
Roma, I Facoltà di Medicina e Chirurgia,
Dipartimento “Cuore e Grossi Vasi Attilio
Reale”.
2008
Conferma nel ruolo di Professore Associato di
Cardiologia presso la medesima Facoltà.
Dicembre 2008-oggi
Affiliazione presso l‟attuale Dipartimento di “Scienze
Cardiovascolari, Respiratorie,
Nefrologiche e Geriatriche”, Università La
Sapienza, I Facoltà di Medicina e
Chirurgia.
ATTIVITA’ CLINICA
1983-1993
Assistente presso l'Istituto di Cardiologia del Policlinico
A Gemelli, nella Facoltà di Medicina e ChirugiaPoliclinico "A. Gemelli"
1993-2005
Aiuto presso l'Istituto di Cardiologia nella Facoltà di
Medicina e Chirurgia del Policlinico A Gemelli.
1983-1990
Attività assistenziale presso l‟Unità Coronarica del
Policlinico Gemelli occupandosi della diagnostica noninvasiva ed invasiva e del trattamento dell‟infarto
miocardico e delle sindromi coronariche acute.
1990-2001
Attività assistenziale presso il Reparto di Cardiologia
dello stesso nosocomio, occupandosi in particolare dello
scompenso cardiaco e delle sue cause incluse la
cardiopatia ischemica le cardiomiopatie e le miocarditi.
1983-2005
Istituzione e direzione del Laboratorio di Biopsia
Endomiocardica, presso l'Istituto di Cardiologia
dell‟Università Cattolica del Sacro Cuore, dedicato
all‟esecuzione dell‟indagine bioptica, all‟interpretazione
istomorfologica dei frammenti bioptici ottenuti ed
all‟applicazione di metodiche di biologia molecolare su
tessuto miocardico congelato. Tale laboratorio ha
espresso continuità operativa fornendo in media 150
procedure diagnostiche l'anno.
2005-2008
Attività assistenziale presso il Dipartimento “Cuore e
Grossi Vasi Attilio Reale dell‟Univeristà la Sapienza di
2
Roma, I Facoltà di Medicina e Chirurgia.
2008-oggi
Attività assistenziale presso il Dipartimento “Scienze
Cardiovascolari, Respiratorie, Nefrologiche e
Geriatriche” dell‟Univeristà la Sapienza di Roma, I
Facoltà di Medicina e Chirurgia.
2005-oggi
Istituzione e direzione dei Laboratori di Cardiologia
Cellulare e Molecolare presso l‟IRCSS L. Spallanzani di
Roma.
ATTIVITA’ SCIENTIFICA
1983-1986
Direzione dell‟Unità Operativa del C.N.R. per il progetto
finalizzato SP4 "Malattie degenerative".
1999-2000
Responsabile dell‟Unità di Ricerca dell‟Università
Cattolica del Sacro Cuore nell‟ambito del Progetto
“Myocarditis: impact of etiological diagnosis based upon
molecular and immunologic findings” finanziato dal
Ministero dell‟Università e della Ricerca Scientifica e
Tecnologica.
2000-2004
Co-Principal Investigator, il N.I.H. RFA Grant per la
ricerca dal titolo “Oxidative stress and Diabetic
Cardiomyopathy” in collaborazione con il Prof. Piero
Anversa.
2001
Finanziamenti alla ricerca dal Ministero della Salute per
lo studio della morte improvvisa giovanile, in
collaborazione con la Prof.ssa Priori (Università di Pavia)
ed il Prof. Thiene (Università di Padova), e per lo studio
delle metalloproteinasi nella cardiomiopatia dilatativa in
collaborazione con la Prof,ssa Arbustini (Università di
Pavia).
2003
Finanziamento Telethon (Grant GGP030344) per il
progetto „Fabry Cardiomyopathy: metabolic impact of
enzyme replacement therapy‟
2004
2005-2007
Responsabile di unità operativa per ricerca sanitaria
finalizzata finanziata dal Ministero della Salute, mediante
la Regione Veneto (nota prot. N. 11834-MdS.DGRSTT
del !7!”/2004) dal titolo: Cardiomiopatie infiammatorie:
eziopatogenesi e trattamenti endocrino-farmacologici per
il recupero della funzione contrattile.
Principal Investigator del grant Telethon n.GGP05264 dal
titolo “Fabry cardiomyopathy: myocardial gene
expression profiling in responders and non responders to
3
enzyme-replacement therapy”.
2008-2009
2009-2012
Finanziamento alla ricerca dal Ministero della Salute per
un progetto bando ex art 56 (2008-2009) dal titolo:
Cardiomiopatiaq infiammatoria HIV-relata e non:
identificazione degli agenti causali e dei meccanismi
patogenetici ai fini di una terapia mirata.
Sono in corso di finanziamento tre progetti del ministero della
Salute:
1) Bando Malattie Rare Ministero della Salute. Titolo del progetto: Enzyme replacement
therapy in the progression of Fabry's disease cardiomyopathy: morphologic biochemical and
molecular characterization (unità operativa)
2) Multicenter randomized study on the efficacy of immunosuppression on
patients with virus-negative myocarditis. RF 2009-1549885 (principal
invastigator)
3) Structural mechanisms of right ventricular remodelling in patients with
pulmonary hypertension (RF 2009) (unità operativa).
ATTIVITA’ DIDATTICA
1983-2005
Incarico di insegnamento presso la Scuola di
Specializzazione in Cardiologia dell‟Università Cattolica
del Sacro Cuore di Roma
2005-oggi
Incarico di insegnamento presso la Scuola di
Specializzazione in Cardiologia II scuola dell‟Università
La Sapienza di Roma I Facoltà di Medicina e Chirurgia-
2006-2010
Docente di “Medicina Interna” presso il corso di Laurea
in “Tecnici di Laboratorio biomedico” dell‟Università La
Sapienza di Roma, sede San Raffaele Pisana.
PREMI E RICONOSCIMENTI:
4
1987
"Young Scholar Award" al 53° Congresso dell'
American College of Chest Physicians per il
lavoro "Myocardial magnesium content in primary
ventricular tachycardia. Relation between myocardial
Mg, histology and antiarrhythmic response to Mg infusion".
APPARTENENZA A SOCIETÀ SCIENTIFICHE
1989
Fellow dell' American College of Chest Physicians.
1989-1993
Membro del Council on Cardiomyopathies of the
'International Society and Federation of Cardiology
1999
Membro del Council on Cardiomyopathies of the
'International Society and Federation of Cardiology.
ATTIVITÀ EDITORIALE
1996
Reviewer della rivista CHEST .
2000-2005
Membro dell‟Editorial Board dell‟Italian Heart Journal
2005-oggi
Reviewer di Circulation, JACC, New England Journal of
Medicine, European Heart Journal, European Journal of
Heart Failure, American Journal of Cardiolog, Lancet,
Journal of Echocardiography, Journal of Infectious
diseases.(allega a riguardo ECM credits da NEJM ed
inclusione del candidato fra i major reviewers della
stessa rivista.
Il Prof Frustaci ha un‟ottima conoscenza della lingua inglese scritta e parlata e ha realizzato le
pubblicazioni scientifiche di seguito elencate.
5
PUBBLICAZIONI SU RIVISTE SCIENTIFICHE CON IMPACT FACTOR
IMPACT FACTOR TOTALE=845
NUMERO DI CITAZIONI=3450
CITAZIONI/ANNO=115
CITAZIONI/LAVORO=31.94
CITAZIONI/AUTORE=767.35
H-INDEX=25
1. Frustaci A, Rebuzzi AG, Schiavoni G, Coppola E, Manzoli U. Potassium depletion. A gap
between cardiac and skeletal muscle damage? Chest 1982;81:528-529.
2. Frustaci A, Anti M, Fedeli G, Devitis I, Rapaccini GL. Hypomagnesaemic hypocalcemia with
high serum IPTH level in caeliac disease: a case report Ital. J. Gastroenterol. 1983;15:181-182
3. Frustaci A, Pennestrì F, Scoppetta C. Myocardial damage due to hypokalemia and
hypophosphatemia. Postgraduate Med. J. 1984;60: 679-681.
4. Magarò M, Ceresia G, Frustaci A. Arthritis of the middle ear in ankylosing spondylitis. Annals
of the Rheumatic diseases 1984;43:655-659.
5. Frustaci A Hypokalemic myocytolysis and rhythm disturbances. Chest 1984;85:836.
6. Frustaci A, Loperfido F, Pennestrì F. Hypertrophic cardiomyopathy simulating an infiltrative
myocardial disease. Br. Heart J. 1985,54.329-332.
7. Frustaci A, Caldarulo M, Cittadini A, Lanza GA, Bellocci F. Myocardial magnesium content in
primary ventricular tachycardia. Relation between myocardial Mg, histology and antiarrhythmic
response to Mg infusion. CHEST 1987;92:985.
8. Frustaci A, Caldarulo M, Schiavoni G, Bellocci F, Manzoli U, Cittadini A. Myocardial
magnesium content, histology and antiarrhythmic response to magnesium infusion. Lancet
1987;2:1019.
9. Frustaci A, Abdulla AK, Possati GF, Manzoli U. Persisting hypereosinophilia and myocardial
activity in the fibrotic stage of endomyocardial disease. CHEST 1989, 96:674-675
10. Frustaci A. Right ventricular dysplasia versus idiopathic dilated cardiomyopathy. Eur Heart J
1989;10 Suppl D:92-94.
11. Antonelli Incalzi A, Gemma A, Frustaci A, et al. Low atrial tachycardia as primary cause of the
heart failure complicating congestive cardiomyopathy. Acta Cardiologica 1989;44:335-339.
12. Abdulla AK, Frustaci A, Martinez JE, Florio RA, Sommerville J, Olsen EGJ.
Echocardiography and pathology of left ventricular "false tendons". CHEST 1990;98:129-132.
6
13. Manzoli U, Rossi E, Littarru GP, Frustaci A, Lippa S et al. Coenzime Q10 in dilated
cardiomyopathy. Int J Tissue React 1990;12:173-8.
14. Frustaci A, Caldarulo M, Di Rienzo V, Russo MA, Gentiloni N. Antiarrhythmic effect of H2
Antihistamines. CHEST 1991;99.262-263.
15. Frustaci A, Loperfido F, Gentiloni N, Caldarulo M, Morgante E, Russo MA. Catecholamineinduced cardiomyopathy in multiple endocrine neoplasia. A histologic, ultrastructural, and
biochemical study. CHEST 1991;99.382-385.
16. Frustaci A, Caldarulo M et al.Cardiac biopsy in patients with "primary" atrial fibrillation.
Histologic evidence of occult myocardial diseases. CHEST 1991;100:303-306.
17. Frustaci A, Russo MA, et al. Reversible dilated cardiomyopathy due to growth hormone
deficiency. Am Journal of Clinical Pathology 1992;97:503-511.
18. Melina D, Colivicchi F, Guerrera G, Melina G, Frustaci A, Caldarulo M, Guerrera
C.Prevalence of left ventricular hypertrophy and cardiac arrhythmias in borderline hypertension.
Am J Hypertens. 1992;5:570-3.
19. Frustaci A, et al. Reversible dilated cardiomyopathy due to growth hormone deficiency.
CHEST 1992;102:326-327.
20. Frustaci A, Maseri A. Localized left ventricular aneurysms with normal global function caused
by myocarditis. Am J Cardiol 1992 ;70:1221-24.
21. Frustaci A, Caldarulo M, Pagliari G. Coronary angyodysplasia causing left ventricular shunt
and myocardial ischemia. Am Heart J 1993;125:889-891.
22. Mirabella M, Servidei S, Manfredi G, Ricci E, Frustaci A, Bertini E, Rana M, Tonali
P.Cardiomyopathy may be the only clinical manifestation in female carriers of Duchenne muscular
dystrophy. Neurology. 1993;43:2342-5.
23. Frustaci A, Caldarulo M, Pagliari G. Coronary angyodysplasia causing left ventricular shunt
and myocardial ischemia. Am Heart J 1993;125:889-891.
24. Zeppilli P, Santini C, Palmieri V, Vannicelli R, Giordano A, Frustaci A. Role of Myocarditis
in Athletes with Minor Arrhythmias and/or Echocardiographic Abnormalities .CHEST
1994;106:373-80.
25. Frustaci A, Lemmo G, Nuzzo G. Basilic Transvenous Biopsy for Investigation of Superior
Vena Caval Syndrome. CHEST 1994;106:1925-26 .
26. Frustaci A, Bellocci F, Olsen EGJ. Results of Biventricular Endomyocardial Biopsy in
Survivors of Cardiac Arrest with Apparently Normal Hearts. Am J Cardiol 1994 ;74:890-895.
27. Booth DR, Tan SY, Hawkins PN, Pepys MB, Frustaci A. A Novel Variant of Transthyretin ,
59thr to lys, Associated with Autosomal Dominant Cardiac Amyloidosis in an Italian Family.
Circulation 1995;91:962-967.
7
28. Frustaci A, Cameli S, Zeppilli P. Byopsy evidence of atrial myocarditis in an athlete developing
transient sino-atrial disease. CHEST 1995; 108: 1460-1462.
29. Frustaci A, Zurlo A, Perrone GA, Russo A, Caldarulo M, Russo MA. Morphometry and
GH/IGF-1 axis deficiency may identify a form of dilated cardiomyopathy which is corrected by
recombinant human growth hormone (rHGH). Ann N Y Acad Sci. 1995;752:422-5.
30. Frustaci A, Caldarulo M et al.Acute myocarditis and left ventricular aneurysm as presentation
of Systemic Lupus Erythematosus. CHEST 1996;109:282-284
31. Minotti G, Mancuso C, Frustaci A, Mordente A, Santini SA, Calafiore AM, Liberi G, Gentiloni
N. Paradoxical inhibition of cardiac lipid peroxidation in cancer patients treated with doxorubicin.
Pharmacologic and molecular re-appraisal of anthracycline cardiotoxicity. J Clin Investigation
1996;98:650-661.
32. Zeppilli P, Santini C, Cameli S, Dello Russo A, Picani C, Giordano A, Frustaci A. Healed
Myocarditis as a Cause of Ventricular Repolarization Abnormalities in Athlete's Heart. Intern J
Sports Med 1997;18:213-16.
33. Frustaci A, Gentiloni N, Russo MA. Growth Hormone in the treatment of Dilated
Cardiomyopathy. N Engl J Med 1996;335:672-674.
34. Frustaci A, Chimenti C, Pieroni M. Idiopathic Myocardial Vasculitis Presenting as Restrictive
Cardiomyopathy. CHEST 1997; 111: 1462-1464.
35. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological Substrate
of Atrial Biopsies in Patients with Lone Atrial Fibrillation. Circulation 1997; 96: 1180-1184.
36. Frustaci A, Chimenti C, Natale L. Right ventricular aneurysm associated with advanced
hypertrophic cardiomyopathy. CHEST 1998; 113:552-554
37. Zeppilli P, Dello Russo A, Santini C, Palmieri V, Natale L, Giordano A and Frustaci A. In vivo
detection of coronary Artery anomalies in Asymptomatic Athletes by Ehocardiographic Screening.
CHEST 1998;114:89-93.
38. Frustaci A, Gentiloni N, Chimenti C, Natale L, Gasbarrini G, Maseri A. Necrotizing
Myocardial Vasculitis in Churg-Strauss Syndrome: Clinico-Histologic Evaluation of Steroids and
immunosuppressive Therapy. CHEST 1998, 114;1484-1489.
39. Frustaci A, Chimenti C, Maseri A. Global bi-ventricular dysfunction in patients with
asymptomatic coronary artery disease may be caused by myocarditis. Circulation
1999;99:1295-1299.
40. Frustaci A, Chimenti C, Setoguchi M, Guerra S, Corsello S, Crea F, Leri A, Kajstura J,
Anversa P, Maseri A. Cell death in acromegalic cardiomyopathy. Circulation. 1999;99:142634.
8
41. Frustaci A, Magnavita N, Chimenti C, Caldarulo M, Sabbioni E, Pietra R, Cellini C,
Possati GF, Maseri A. Marked elevation of myocardial trace elements in idiopathic dilated
cardiomyopathy compared to secondary cardiac dysfunction. J Am Coll Cardiol
1999;33:1578-1583.
42. Frustaci A, Chimenti C, Maseri A. Reply to “Mercury and idiopathic dilated
cardiomyopathy”. J Am Coll Cardiol 2000; 35: 819.
43. Frustaci A, Chimenti C, Pieroni M, Gentiloni N. Giant cell myocarditis responding to
immunosuppressive therapy. CHEST 2000; 117:905-907.
44. Frustaci A, Chimenti C, Pieroni M. Coronary angiodysplasia of epicardial and intramural
vessels. CHEST 2000;118(5):1511-3.
45. Frustaci A, Chimenti C, Pieroni M. Prognostic significance of left ventricular aneurysms
with normal global function caused by myocarditis. CHEST 2000;118(6):1696-702
46. Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B, Anversa
P. Myocardial cell death in human diabetes. Circ Res. 2000;87(12):1123-32.
47. Chimenti C, Calabrese F, Thiene G, Pieroni M, Maseri A, Frustaci A. Inflammatory left
ventricular microaneurysms as a cause of apparently idiopathic ventricular tachyarrhythmias.
Circulation. 2001;104:168-73.
48. Frustaci A, Chimenti C, Ricci R, Natale L, Russo MA, Pieroni M, Eng CM, Desnick RJ.
Improvement in cardiac function in the cardiac variant of Fabry's disease with galactoseinfusion therapy. N Engl J Med. 2001;345:25-32.
49. Chimenti C, Pieroni M, Frustaci A. Endomyocardial fibrosis mimicking a dilated
cardiomyopathy in a child. Heart. 2001;86:73.
50. Frustaci A, Pieroni M, Chimenti C.Late-onset primary LVH HCM versus cardiac fabry
variant. J Am Coll Cardiol. 2002;39:1405-6.
51. Frustaci A, Cuoco L, Chimenti C, Pieroni M, Fioravanti G, Gentiloni N, Maseri A,
Gasbarrini G. Celiac disease associated with autoimmune myocarditis. Circulation
2002;105:2611-8.
52. Frustaci A, Calabrese F, Chimenti C, Pieroni M, Thiene G, Maseri A. Lone HCV
myocarditis responsive to immunosuppressive therapy. CHEST. 2002;122:1348-56.
53. Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A. Immunosuppressive
therapy for active lymphocytic myocarditis: virologic and immunologic profile of responders
vs non-responders. Circulation 2003;107:857-63.
54. Chimenti C, Kajstura J, Torella D, Urbanek K, Heleniak H, Colussi C, Di Meglio F, NadalGinard B, Frustaci A, Leri A, Maseri A, Anversa P.Senescence and Death of Primitive Cells
9
and Myocytes Leads to Premature Cardiac Aging and Heart Failure. Circ Res. 2003 Oct
3;93(7):604-13.
55. Frustaci A, Pieroni M, Chimenti C. Immunosuppressive therapy in inflammatory
cardiomyopathy. Eur Heart J Suppl January 2003.
56. Pieroni M, Chimenti C, Ricci R, Sale P, Russo MA, Frustaci A. Early Detection Of Fabry
Cardiomyopathy By Tissue Doppler Imaging. Circulation. 2003;107:1978-84.
57. Chimenti C, Pieroni M, Maseri A, Frustaci A. Histologic findings in patients with clinical
and instrumental diagnosis of sporadic Arrhythmogenic Right Ventricular Dysplasia. J Am
Coll Cardiol. 2004;43:2305-13.
58. Chimenti C, Pieroni M, Antuzzi D, Morgante E, Russo MA, Maseri A, Frustaci A.
Prevalence of Fabry Disease in female patients with hypertrophic cardiomyopathy.
Circulation 2004. 31;110:1047-53.
59. Calabrese F, Carturan E, Chimenti C, Pieroni M, Agostini C, Angelini A, Crosato M,
Valente M, Boffa GM, Frustaci A, Thiene G. Over-expression of Tumor Necrosis Factor
(TNF)- and TNF- receptor I in human viral myocarditis: clinico-pathologic correlations.
Mod Pathol. 2004;17:1108-18.
60. Pieroni M, Chimenti C, Russo A, Russo MA, Maseri A, Frustaci A. Tissue Doppler in Fabry
disease. Review. Curr Opin Cardiol. 2004;19:452-457.
61. Chimenti C, La Penna E, Pieroni M, San Vito F, Alfieri O, Maseri A, Frustaci A. Coronary
and valve angiodysplasia unmasked by eosinophilic vasculitis and endomyocarditis. CHEST
2004 Nov;126:1700-3.
62. Pieroni M, Cavallaro R, Chimenti C, Smeraldi E, Frustaci A. Clozapine-induced
hypersensitivity myocarditis. CHEST 2004;126:1703-5.
63. Chimenti C, Russo A, Pieroni M, Calabrese F, Verardo R, Thiene G, Russo MA, Maseri A,
Frustaci A. Intramyocyte detection of Epstein-Barr virus genome by laser capture
microdissection in patients with inflammatory cardiomyopathy. Circulation. 2004
7;110:3534-9.
64. Pieroni M, Chimenti C, Frustaci A. Letter regarding article by Nanthakumar et al,
"electrophysiological findings in adolescents with atrial fibrillation who have structurally
normal hearts". Circulation. 2005;111:e27; author reply e27.
65. Chimenti C, Pieroni M, Frustaci A. Letter regarding article by Abbate et al, "widespread
myocardial inflammation and infarct-related artery patency". Circulation. 2005;111:e17;
author reply e17.
66. Chimenti C, Pieroni M, Russo A, Sale P, Russo MA, Maseri A, Frustaci A. Laser
microdissection in clinical cardiovascular research. CHEST 2005;128:2876-2881.
10
67. Frustaci A, Priori SG, Pieroni M, Chimenti C, Napolitano C, Rivolta I, Sanna T, Bellocci F
and MA Russo. Cardiac histologic substrate in patients with clinical phenotype of Brugada
syndrome. Circulation 2005;112:3680-7.
68. Pieroni M, Chimenti C, Frustaci A. “Hissing snake” left ventricle. Thrombotic phase of
hypereosinophilic endomyocardial disease. Eur Heart J 2006;27:778.
69. Frustaci A, Pieroni M, Chimenti C. Immunosuppressive treatment of chronic non-viral
myocarditis. Ernst Schering Res Found Workshop. 2006; 55:343-51.
70. Chimenti C, Pieroni M, Frustaci A. Myocarditis: when to suspect and how to diagnose it in
athletes. Journal of Cardiovascular Medicine 2006 Apr;7(4):301-6. Review .
71. Cooper LT, Virmani R, Chapman NM, Frustaci A, Rodeheffer RJ, Cunningham MW,
McNamara DM. National Institute of Health-Sponsored Workshop on Inflammation and
Immunity in Dilated cardiomyopathy. Mayo Clin Proc 2006;81:199-204.
72. Decobelli F, Pieroni M, Esposito A, Chimenti C, Belloni E, Mellone R , Canu T, Perseghin
G , Gaudio C , Maseri A , Frustaci A, Del Maschio A. Delayed gadolinium-enhanced
cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure
or recurrent arrhythmias. JACC 2006 Apr 18;47(8):1649-54.
73. Frustaci A, Chimenti C, Pieroni M, salvatori L, Morgante E, Sale P, Ferretti E, Petrangeli E,
Gulino A and MA Russo. Cell death, proliferation and repair in humen myocarditis
responding to immunosuppressive therapy. Modern Pathology 2006;19(6):755-65.
74. Pieroni M, Chimenti C, F De Cobelli , E Morgante , Gaudio C, M A Russo, Frustaci A.
Fabry cardiomyopathy: echocardiographic detection of endomyocardial glycosphingolipids
compartmentalization. JACC 2006 Apr 18;47:1663-71.
75. Chimenti C, Pieroni M, Frustaci A. Myocarditis: when to suspect and how to diagnose it in
athletes. Journal of Cardiovascular Medicine 2006 Apr;7(4):301-6. Review .
76. Frustaci A, Verardo R, Caldarulo M, Acconcia MC, Russo MA and Chimenti C. Myocarditis
in hypertrophic cardiomyopathy patients presenting acute clinical deterioration. Eur Heart J
2007; 28: 733-740.
77. Chimenti C, Del Nonno F, Topino S, Abbate I, Licci S, Paglia MG, Capobianchi MR,
Petrosillo N, Frustaci A. Fatal myocardial coinfection by Toxoplasma Gondii and Parvovirus
B19 in an HIV patient. AIDS 2007; 21(10):1386-1388.
78. Frustaci A, Verardo R, Sale P, Toscano F, Critelli G, Russo MA, Chimenti C.
Hypersensitivity myocarditis induced by beta-blockers: an unexpected cause of abrupt
deterioration in hypertrophic cardiomyopathy. Intensive Care Med 2007; 13:380-8.
79. Chimenti C, Morgante E, Critelli G, Russo MA, Frustaci A. Coronary artery bypass grafting
for Fabry‟s disease: veins more suitable than arteries? Hum Pathol 2007; 38(12):1864-7.
11
80. Frustaci A, Chimenti C. Images in cardiovascular medicine. Cryptogenic ventricular
arrhythmias and sudden death by Fabry disease: prominent infiltration of cardiac conduction
tissue. Circulation 2007; 116(12):e350-1.
81. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, Levine GN,
Narula J, Starling RC, Towbin J, Virmani R. The role of endomyocardial biopsy in the
management of cardiovascular disease: A Scientific Statement from the American Heart
Association, the American College of Cardiology, and the European Society of Cardiology
Endorsed by the Heart Failure Society of America and the Heart Failure Association of the
European Society of Cardiology. Eur Heart J. 2007; 28(24):3076-93.
82. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, Levine GN, Narula
J, Starling RC, Towbin J, Virmani R; American Heart Association; American College of
Cardiology, and the European Society of Cardiology. The role of endomyocardial biopsy in
the management of cardiovascular disease: a scientific statement from the American Heart
Association, the American College of Cardiology, and the European Society of Cardiology.
Circulation. 2007 Nov 6;116(19):2216-33.
83. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, Levine GN, Narula
J, Starling RC, Towbin J, Virmani R; American Heart Association; American College of
Cardiology, and the European Society of Cardiology, Heart Failure Society. The role of
endomyocardial biopsy in the management of cardiovascular disease: a scientific statement
from the American Heart Association, the American College of Cardiology, and the
European Society of Cardiology. Endorsed by the Heart Failure Society of America and the
Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol. 2007
Nov 6;50(19):1914-31.
84. Chimenti C, Morgante E, Critelli G, Russo MA, Frustaci A. Coronary artery bypass grafting
for Fabry‟s disease: veins more suitable than arteries?. Hum Pathol 2007; 38:1864-7.
85. Chimenti C, Hamdani N, Boontje NM, DeCobelli F, Esposito A, Bronzwaer JGF, Stienen
GJM, Russo MA, Paulus WJ, Frustaci A, van der Velden J. Myofilament Degradation and
Dysfunction in Human Cardiomyocytes with Fabry Disease. Am J Pathol 2008;172:1482-90.
86. Chimenti C, Agrusta M, Cioppa A, Campopiano E, Rubino P, Frustaci A.Auto-reactive myocarditis
after percutaneous closure of an atrial septal defect. Intensive Care Med. 2008
Nov;34(11):2121-2.
87. Esposito A, De Cobelli F, Perseghin G, Pieroni M, Belloni E, Mellone R, Canu T, Gentinetta F, Scifo P,
Chimenti C, Frustaci A, Luzi L, Maseri A, Del Maschio A.Impaired left ventricular energy
metabolism in patients with Hypertrophic Cardiomyopathy is related to the extension of
Fibrosis at Gadolinium Delayed Enhanced MR Imaging. Heart. 2008 Aug 15. [Epub ahead
of print]
88. Chimenti C,Morgante E, Tanzilli G, E Mangieri, G Critelli, C Gaudio, MA Russo, A
Frustaci. Angina in Fabry‟s disease reflects coronary small vessel disease. Circulation Heart
Failure 2008;1:161-169.
12
89. Chimenti C, Frustaci A. Histopathology of myocarditis. Review. Diagnostic Histopathology
2008;14:401-407.
90. Mehta A, Beck M, Kampmann C, Frustaci A, Germain DP, Pastores GM, Sunder-Plassmann
G. Enzyme replacement therapy in Fabry disease: comparison of agalsidase alfa
and agalsidase beta. Mol Genet Metab. 2008 Sep-Oct;95(1-2):114-5. Epub 2008 Aug 12
91. Esposito A, De Cobelli F, Perseghin G, Pieroni M, Belloni E, Mellone R, Canu T,
Gentinetta F, Scifo P, Chimenti C, Frustaci A, Luzi L, Maseri A, Maschio AD. Impaired
left ventricular energy metabolism in patients with hypertrophic
cardiomyopathy is related to the extension of fibrosis at delayed gadoliniumenhanced magnetic resonance imaging. Heart. 2009 Mar;95(3):228-33. Epub 2008
Aug 15.
92. De Cobelli F, Esposito A, Belloni E, Pieroni M, Perseghin G, Chimenti C, Frustaci A, Del
Maschio A. Delayed-enhanced cardiac MRI for differentiation of Fabry's
disease from symmetric hypertrophic cardiomyopathy. AJR Am J Roentgenol.
2009 Mar;192(3):W97-102.
93. Frustaci A, Russo MA, Chimenti C. Structural myocardial abnormalities in
asymptomatic family members with Brugada syndrome and SCN5A gene
mutation. Eur Heart J. 2009 Jul;30(14):1763. Epub 2009 May 2.
94. Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of
immunosuppressive therapy in patients with virus-negative inflammatory
cardiomyopathy: the TIMIC study. Eur Heart J. 2009 Aug;30(16):1995-2002.
95. Chimenti C, Morgante E, Tanzilli G, Mangieri E, Critelli G, Gaudio C, Russo MA, Frustaci
A. Angina in fabry disease reflects coronary small vessel disease. Circ Heart
Fail. 2008 Sep;1(3):161-9
96. Elia L, Contu R, Quintavalle M, Varrone F, Chimenti C, Russo MA, Cimino V, De Marinis
L, Frustaci A, Catalucci D, Condorelli G. Reciprocal regulation of microRNA-1 and
insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal
muscle in physiological and pathological conditions. Circulation. 2009 Dec
8;120(23):2377-85. Epub 2009 Nov 23.
97. Chimenti C, Russo MA, Carpi A, Frustaci A. Histological substrate of human atrial
fibrillation. Biomed Pharmacother. 2010 Mar;64(3):177-83.
98. Scarpa M, Frustaci A. Novel therapies and future perspectives. Int J Clin Pharmacol Ther.
2009;47 Suppl 1:S109-10.
99. Frustaci A. Cytopathic pathways of enteroviral myocardial infection. Eur Heart J. 2010
Mar;31(6):637-9. Epub 2010 Jan 26.
100. Carbone I, Francone M, Chimenti C, Galea N, Russo M, Frustaci A. Images in
cardiovascular medicine: Right ventricular late enhancement as a magnetic resonance marker
of glycogen storage disease. Circulation. 2010 Jul 13;122(2):189-90.
13
101. Chimenti C, Russo MA, Frustaci A. Atrial biopsy evidence of Fabry disease causing lone
atrial fibrillation. Heart. 2010 Nov;96(21):1782-3. Epub 2010 Aug 23.
102. Chimenti C, Sale P, Verardo R, Cicalini S, Petrosillo N, Russo MA, Fedele F, Frustaci
A. High prevalence of intramural coronary infection in patients with drug-resistant cardiac
syndrome X: comparison with chronic stable angina and normal controls. Heart. 2010
Dec;96(23):1926-31. Epub 2010 Oct 3. Erratum in: Heart. 2010 Dec;96(24):2045
103. Pieruzzi F, Pieroni M, Chimenti C, Frustaci A, Sarais C, Cecchi F; Area CardiologicaAdvisory Board Plan Multidisciplinare "Diagnosi e Follow-up Malattia di
Fabry".Cardiological follow-up in patients with Fabry disease. G Ital Cardiol
(Rome). 2010 Jul-Aug;11(7-8):566-72. Review.
104. Carbone I, Francone M, Galea N, Benedetti G, Frustaci A. Images in cardiology. Computedtomography and magnetic resonance imaging assessment of traumatic left anterior descending coronary
dissection causing acute myocardial infarction. J Am Coll Cardiol. 2011 Jan 11;57(2):e3
105. Colussi C, Rosati J, Straino S, Spallotta F, Berni R, Stilli D, Rossi S, Musso E, Macchi
E, Mai A, Sbardella G, Castellano S, Chimenti C, Frustaci A, Nebbioso A, Altucci L,
Capogrossi MC, Gaetano C. Nε-lysine acetylation determines dissociation from GAP
junctions and lateralization of connexin 43 in normal and dystrophic heart. Proc Natl Acad
Sci U S A. 2011 Feb 15;108(7):2795-800. Epub 2011 Jan 31
106. . Frustaci A, Lanfranchi G, Bellin M, Chimenti C. Coronary telangiectasia associated
with hypertrophic cardiomyopathy. Eur J Heart Fail. 2012 Dec;14(12):1332-7. doi:
10.1093/eurjhf/hfs125. Epub 2012 Aug 5. 107.
107. Frustaci A, Morgante E, Antuzzi D, Russo MA, Chimenti C Inhibition of
cardiomyocyte lysosomal activity in hydroxychloroquine cardiomyopathy.. Int J Cardiol.
2012 May 17;157(1):117-9. doi: 10.1016/j.ijcard.2012.03.112. Epub 2012 Apr 4.
108. Brisinda D, Sorbo AR, Venuti A, Ruggieri MP, Manna R, Fenici P, Wallukat G,
Hoebeke J, Frustaci A, Fenici R. Anti-β-adrenoceptors autoimmunity causing 'idiopathic'
arrhythmias and cardiomyopathy. Circ J. 2012;76(6):1345-53. Epub 2012 Mar 22.
109. Chimenti C, Padua L, Pazzaglia C, Morgante E, Centurion C, Antuzzi D, Russo MA,
Frustaci A. Cardiac and skeletal myopathy in Fabry disease: a clinicopathologic correlative
study. Hum Pathol. 2012 Sep;43(9):1444-52. doi10.1016/j.humpath.2011.09.020. Epub 2012
Mar 8.
110. Frustaci A, Sabbioni E, Fortaner S, Farina M, del Torchio R, Tafani M, Morgante E,
Ciriolo MR, Russo MA, Chimenti C. Selenium- and zinc-deficient cardiomyopathy in
human intestinal malabsorption: preliminary results of selenium/zinc infusion. Eur J Heart
Fail. 2012 Feb;14(2):202-10. doi: 10.1093/eurjhf/hfr167. Epub 2011 Dec 20.
111. . Chimenti C, Frustaci A.Contribution and risks of left ventricular endomyocardial
biopsy in patients with cardiomyopathies: a retrospective study over a 28-year period.
Circulation. 2013 Oct 1;128(14):1531-41. doi: 10.1161/CIRCULATIONAHA.13.001414.
Epub 2013 Sep 4.
112. . Iacucci I, Carbone I, Cannavale G, Conti B, Iampieri I, Rosati R, Sardella G, Frustaci
A, Fedele F, Catalano C, Francone M. Myocardial oedema as the sole marker of acute injury
in Takotsubo cardiomyopathy: a cardiovascular magnetic resonance (CMR) study. Radiol
Med. 2013 May 28. [Epub ahead of print]
14
113. . Galea N, Carbone I, Cannata D, Cannavale G, Conti B, Galea R, Frustaci A, Catalano
C, Francone M. Right ventricular cardiovascular magnetic resonance imaging: normal
anatomy and spectrum of pathological findings. Insights Imaging. 2013 Apr;4(2):213-23.
doi: 10.1007/s13244-013-0222-3. Epub 2013 Feb 8.
114.
Frustaci A, Francone M, Petrosillo N, Chimenti C. High prevalence of myocarditis in
patients with hypertensive heart disease and cardiac deterioration. Eur J Heart Fail. 2013
Mar;15(3):284-91. doi: 10.1093/eurjhf/hfs169. Epub 2012 Oct 30.
115. . Frustaci A, Russo MA, Chimenti C Diagnostic contribution of left ventricular
endomyocardial biopsy in patients with clinical phenotype of hypertrophic cardiomyopathy.
Hum Pathol. 2013 Jan;44(1):133-41. doi: 10.1016/j.humpath.2012.04.023. Epub 2012 Aug
30.
116. Francone M; Chimenti C; Galea N, Scopelliti F, Verardo R, Galea R, Carbone I,
Catalano C, Fedele F, Frustaci A .CMR sensitivity varies with clinical presentation and
extent of cell necrosis in biopsy-proven acute myocarditis. J Am Coll Cardiol Img. Published
online February 19, 2014. doi:10.1016/j.jcmg.2013.10.011
PUBBLICAZIONI SU RIVISTE SCIENTIFICHE SENZA IMPACT FACTOR
1.
E.Scabbia, F. Bellocci, G. Schiavoni, E. Coppola, B. Domenichelli, A. Frustaci. La terapia
con farmaci vasodilatatori nell'infarto miocardico acuto: contributo casistico. Q.I: Cardiovasc. Ric.
1980; 1:35-48.
2.
Frustaci A, Rebuzzi AG, Schiavoni G, Coppola E, Uncini A. Cardiac performance during
hypokalemic rhabdomyolysis. G Ital Cardiol. 1980;10:1570
3.
Frustaci A, Gentiloni N, Feoli F Amyloidosis in a mixed pattern. Sensitivity to colchicine
and melphalan. Minerva Medica 1981;72:957-960.
4.
Coppola, A. Frustaci, G. Schiavoni, R. Mongiardo, A. Ferrazza. Modificazioni cardiache in
corso di sindrome di Schmidt. Q. I. Cardiovasc. Ric. 1981;2:99-102.
5.
Frustaci, U. Manzoli. Soluzioni polarizzanti: utilità e precauzioni. G. Clinica e
Fisiopatologia cardiovascol. 1982;1:189-190.
6.
Pennestri F, Mongiardo R, Comparato C, Digaetano A, Mazzari M, Salvatori MP, Frustaci
A, Loperfido F. The electrocardiographic picture of left atrial disorder is not dependent on the form
and entity of atrial enlargement. Bidimensional echocardiographic study. Cardiologia 1982;2:163171.
7.
Frustaci A, Manzoli U. Methodology, problems and prospectives of endomyocardial
biopsy. Cardiologia 1982;27:1133-1139.
15
8.
Mongiardo R, Mazzari M, Schiavoni G, Frustaci A, Lanza G, Pennestrì F. Hemodynamicangiographic parameters and histomorphologic biopsy findings in patients with suspected idiopathic
dilated cardiomyopathy. Cardiologia 1982;27:1147-1153.
9.
Montenero AS, Frustaci A, Gianolla F, Pennestrì F, Santarelli P, Bellocci F. Clinical,
electrophysiologic and histologic findings in a case of substained idiopathic ventricular tachycardia.
Cardiologia 1982;27:1155-1161.
10.
Mongiardo, F. Pennestri, M.P. Salvatori, A. Digaetano, M. Mazzari, A. Frustaci, A.G.
Rebuzzi, A. Ferrazza Diagnosi con Eco 2D di aneurisma del ventricolo sinistro. Clin. Europea
1982; 2: 3-6.
11.
Mongiardo, F. Pennestrì, M. P. Salvatori, C. Comparato, M. Mazzari, B. Marino, A.
Digaetano, A. Frustaci. Diagnosi di sede nei versamenti pericardici con ecocardiografia
bidimensionale. Clinica Europea 1982;4:3-8.
12.
Mazzari, G. Schiavoni, F. Pennestrì, R. Mongiardo, G. Fiamma, A. Frustaci, A. Digaetano
A, S. Montenero. L'elettrocardiografia dinamica in età pediatrica. Q.I. Cardiovasc. Ric. 1982;3:1520
13.
Mongiardo, F. Pennestrì, M.P: Salvatori, A. Digaetano, M. Mazzari, A. Frustaci A:S:
Montenero. Aspetti ecocardiografici mono e bidimensionali della mitrale in un caso di
mucopoisaccaridosi tipo II. Q.I. Cardiovasc. Ric. 1982;3:21-27.
14.
Montenero, M. Mazzari, R. Mongiardo, A. Frustaci, A. Digaetano, E. Coppola. Ventricolo
destro a doppia uscita : un esempio di connessione ventricolo arteriosa anomala. Embriologia,
anatomia, fisiopatologia, quadri clinico-strumentali, possibilità chirurgiche. Q.I. Cardiovasc. Ric.
1982;3:29-34.
15.
Pennestrì, R. Mongiardo, M.P. Salvatori, M. Mazzari, A. Digaetano, A:S: Montenero, A.
Frustaci, G. Schiavoni. Attendibilità dell'Eco 2D nella stima di parametri emodinamici nell'infarto
acuto del miocardio. Q. I. Cardiovasc. Ric. 1982;3:35-41.
16.
Mazzari, G. Schiavoni, A. S. Montenero, A. Frustaci, A. Digaetano, R. Mongiardo, F.
Pennestrì. Pseudoaneurisma post-chirurgico del ventricolo sinistro. Descrizione di un caso. Q.I.
Cardiovasc. Ric. 1982;3:43-50.
17.
AS Montenero, M. Mazzari, F. Pennestrì, R. Mongiardo, A. Frustaci, B. Domenichelli, M.
Lucente, L.M. Biasucci, et al. L'ECG dinamico nel volo simulato: aspetti fisiopatologici e clinici.
Q.I. Cardiovasc. Ric. 1982;3:51-63.
18.
Frustaci, F. Pennestrì, M. Mazzari, R. Mongiardo, A. S. Montenero, A. Digaetano. Danno
miocardico da ipofosfatemia. Q.I. Cardiovasc. Ric. 1982; 3:73-75.
19.
Schiavoni G, Mazzari M, Lanza GA, Frustaci A, Mongiardo R, Pennestrì F. Evaluation of
the efficacy and the length of action of a new preparation of slow-release nitroglycerin for
percutaneous absorption (Nitro-Dur, Sigma-Tau) in angina pectoris caused by exercise. Int. J. Clin.
Pharm. Res. 1982; Suppl.1,2.15-20.
16
20.
Frustaci, N. Gentiloni, G. Coiana, F. Breccia Ectopic calcifications in adult
hypophosphatasia. Minerva Medica 1983;74:1651-1654.
21.
Dei Cas L, Biasucci LM, Buia E, Frustaci A, Manca C, Metra M, Rebuzzi AG. Circadian
aspects of the heart rate in atrial fibrillation patients: the comparative effect of digoxin and
pentaformylgitoxin. Cardiologia. 1983;28:1019-25.
22.
Sabatelli M, Casali C, Scoppetta C, Frustaci A, Tonali P. Familial amyloid polyneuropathy.
Description of 2 cases treated with dimethylsulfoxide. Riv Neurobiol. 1984;30:261-7.
23.
Mazzari M, Montenero AS, Frustaci A, Lucente M, Mongiardo R, Rebuzzi AG. Late
ventricular arrhythmias in myocardial infarct. Relations with angiographic data. Cardiologia.
1984;29:353-8.
24.
Frustaci A, Schiavoni G, Pennestrì F, Ferri T, Lippa S, Oradei A, Littarru G, Manzoli U.
Coenzyme Q10 in dilated cardiomyopathy: a biochemical approach to the treatment. Preliminary
data. Cardiologia 1985;30:1-4.
25.
Schiavoni G, Mazzari M, Mongiardo R, Frustaci A, Rebuzzi AG, Pennestri F, Amico C,
Bosimini E, Albanese S, Manzoli U. Nitroglycerin by transdermal route in chronic congestive heart
failure. Cardiologia. 1985;30:1145-51.
26.
Manzoli U, Frustaci A, Mazzari M. Dilated Cardiomyopathy. Endomyocardial biopsy.
Cardiologia 1985;30:895-899.
27.
Frustaci A, Caldarulo M, Schiavoni G, Coppola E, Bellocci F, Manzoli U. Ventricular
endomyocardial biopsy in "primary" atrial fibrillation. Cardiologia 1986;31:385-388.
28.
Frustaci A, Manzoli U. Endomyocardial biopsy of the right ventricle. Cardiologia
1986;31:1001-1005.
29.
Frustaci A, Bellocci F, Santarelli P, Manzoli U. Endomyocardial biopsy findings in young
patients with non-sustained ventricular tachycardia and apparently normal heart. In "New trends in
Arrhythmias"; Vol I 1986 pag. 483-486.
30.
Manzoli U, Schiavoni G, Frustaci A. Usefulness and limitations of endomyocardial biopsy.
Cardiologia. 1987;32:1483-6.
31.
Frustaci, M. Caldarulo, et al. Hypertrophic cardiomyopathy mimicking athlete heart. Risk
of progression and opportunity for a bioptical approach. Cardiologia 1989;34:93-5.
32.
Baruffi, S. Bartoccioni, A. Frustaci, et al. Persistenza di ipereosinofilia ed attività
miocardica nella fase fibrotica della malattia endomiocardica. Implicazioni medico chirurgiche.
Archivio di Chir. Toracica e Cardiovascolare Vol. XI 1989;5.
33.
Abdulla, A. Frustaci, et al. Congenital lymphangiectasia of interventricular septum.
Cardiologia 35:433-434,1990.
17
34.
Frustaci A, Abdulla AK, Caldarulo M, Buffon A. Fatal measles myocarditis. Cardiologia
1990;35:347-349.
35.
Abdulla AK, Frustaci A, Amorim D, Olsen EGJ. Assessment of neuron in congenital heart
disease with heart failure. Am Journal of Cardiovascular Pathology 1990;3:265-270.
36.
Mori R, Corvaglia AG, Frustaci A. An unusual chronic microvasculitis: Goodpasture's
syndrome with late myocardial involvement. Recenti Prog Med. 1992;83:649-51.
37.
Manna R, Liang L, De Santis A, Luchetti R, Antico L, Cristiano G, Frustaci A, Gambassi
G. DR4 HLA Association in the dilated cardiomyopathy. Eur J Int Med 1992;2:213-216.
38.
Santarelli P, Frustaci A, Sgadari A, Di Gennaro M, Alessandrini F, Montenero AS, Natale
A, Pisanò E, Biscione F, Carbonin PU, Possati GF. Comparison of atrial electrophysiologic,
histologic and mechanical characteristics in patients with and without atrial fibrillation associated
with the Wolff-Parkinson White syndrome. New trends in arrhythmias-X International Congress
January 1992 pag 289-294.
39.
Frustaci A, CaldaruloM, et al.Cardiac biopsy in patients with "primary" atrial fibrillation.
Histologic evidence of occult myocardial diseases. New trends in arrhythmias-X International
Congress January 1992 pag. 732-752.
40.
Zeppilli P, Corsetti R, Santini C, Merlino B, Palmieri V, Cameli S, Vannicelli R, La Rosa
Gangi M, Giordano A, Frustaci A, Bellocci F. Differentiation between arrhythmogenic right
ventricular cardiomyophathy and athlete's heart. New trends in arrhythmias X international
Congress January 1992 pag.165-169.
41.
MaseriA, Frustaci A. Le infezioni cardiache. Il punto di vista del cardiologo. Giornale di
malattie infettive e parassitarie 1993; 45: 551-555.
42.
Santini C, Dello Russo A, Palmieri V, Vannicelli R, Cameli s, Caretta F, Frustaci A,
Zeppilli P. Middle term follow-up in athletes with arrhythmias due to myocarditis. The New
Frontiers of Arrhythmias XII International congress Marilleva 1996; pag 35-42.
43.
De Santis A, Fenici R, Frustaci A, Romito A, Manna R. Recurrent Perimyocarditis
Following a non penetrating Chest Trauma. A Case Report. Giornale Italiano Cardiologia 1996;26:
57-60.
44.
C Chimenti, A. Frustaci, M Pieroni, A Maseri. Histologically proven myocarditis in patients
with biventricular dysfunction and severe asymptomatic coronary artery disease. Cardiologia
1999;44:177-180.
45.
C Chimenti, R Ricci, M Pieroni, L Natale and A Frustaci. Cardiac variant of Fabry's disease
mimiking a hypertrophic cardiomyopathy. Cardiologia 1999, 44:469-473.
46.
Chimenti C, Pieroni M, Frustaci A. Celiac disease in idiopathic dilated cardiomyopathy. Ital
Heart J. 2001;2:658-9.
18
47.
Chimenti C, Pieroni M, Frustaci A. Celiac disease in idiopathic dilated cardiomyopathy:
reply of the authors. Ital Heart J. 2001;2:658-9.
48.
Chimenti C, Frustaci A. Histopathology of myocarditis. Review. Diagnostic Histopathology
2008;14:401-407.
19
COMUNICAZIONI IN CONGRESSI INTERNAZIONALI
1.
Rebuzzi, M. Formichi, C. Patrono, E. Scabbia, A. Frustaci, G. Schiavoni. Primary
pulmonary hypertension: effects of hydralazine, indomethacin and isoproterenol Comunicazione IX
Congresso Mondiale Cardiologia, Mosca 1982.
2.
Sandric, P. Santarelli, G. Ghirlanda, L. Uccioli, F. Bellocci, A. Frustaci, A.Greco, U.
Manzoli Electrophysiologic effects of Somatostatin in man. Circulation 1984; n4, vol.70, Part II
(Abstract).
3.
Frustaci A., Manzoli U., Lippa S., Oradei A., Littarru G. P., and Folkers K. Blood and
intramyocardial levels of Ubiquinone in dilated cardiomyopathy, a biochemical approach to Co Q10
therapy. 5th International Symposium on Coenzyme Q. Tokio 24-26 october 1985.
4.
Frustaci, M. Caldarulo, F. Bellocci, G. Schiavoni, U. Manzoli. Endomyocardial biopsy
findings in young patients with ventricular tachycardia and apparently normal heart. 6th European
Congress on Diseases of the Chest.Tel Aviv, Israel, June 15-19, 1986.
5.
Gaetano A. Lanza, Antonio G. Rebuzzi, Michele Lucente, Antonio Spagnolo, Andrea
Frustaci, Elda Coppola, Ugo Manzoli. Ventricular arrhythmias in idiopathic dilated
cardiomyopathy. Abstract for World Congress of Cardiology.Washington 14-16 september 1986.
6.
Andrea Frustaci. Ruolo della biopsia endomiocardica nelle cardiomiopatie.
Esemplificazioni anatomo-cliiche. International Academy of Pathology, Abano Terme 4-5 ottobre
1986
7.
Antonio Nobile, Andrea Frustaci, Federico Giannolla, Marina Caldarulo, Gerardo
Ansalone, Sandro Montenero, Enrico Scabbia, Fulvio Bellocci. Ventricular tachycardia in patients
with "idiopathic" mitral valve prolapse: histologic demostration of associated primary myocardial
abnormalities. JACC abstract 36th Annual Scientific Session American College of Cardiology; New
Orleans, march 8-12 1987.
8.
Federico Giannolla, Andrea Frustaci, Antonio Nobile, Gerardo Ansalone, Marina
Caldarulo, Sandro Montenero, Fulvio Bellocci. Apparently idiopathic sustained ventricular
tachycardia responsive to metoprolol in young patients: histologic evidence of silent
cardiomyopathy. JACC abstract 36th Annual Scientific Session American College of Cardiology;
New Orleans march 8-12 1987.
9.
Frustaci, A. Nobile, G. Ansalone, M. Caldarulo, S. Montenero, F. Bellocci. Apparently
idiopathic sustained ventricular tachycardia responsive to metoprolol in young patients: histologic
evidence of silent cardiomyopathy. PACE 1987;10:985.
10.
Frustaci, A. Nobile, G. Ansalone, M. Caldarulo, S. Montenero, F. Bellocci. Ventricular
tachycardia in patients with "idiopathic" mitral valve prolapse: histologic evidence of associated
primary myocardial abnormalities. PACE 1987;10:986.
11.
Frustaci, M. Caldarulo, F. Bellocci, M.A. Russo, U. Manzoli, A. Cittadini. Myocardial
magnesium content in primary ventricular tachycardia. Relation between myocardial Mg, histology
20
and antiarrhythmic response to Mg infusion. The new frontiers of arrhythmias Marilleva january 31february 6;1988
12.
Bellocci, A. Frustaci, A. Nobile, M. Caldarulo, A. Spampinato, S. Montenero. Apparently
idiopathic sustained ventricular tachycardia responsive to metoprolol in young patients: histologic
evidence of silent cardiomyopathy. European Heart J. october 1987.
13.
Ansalone, A. Frustaci, A. Nobile, V. Affinito, M. Caldarulo, S. Montenero, F. Bellocci.
Apparently idiopathic sustained ventricular tachycardia responsive to metoprolol in young patients:
histologic evidence of silent cardiomyopathy. Latido 1987;12:32.
14.
A.Nobile, A. Frustaci, V. Affinito, M. Caldarulo, G. Ansalone, S. Montenero, E. Scabbia,
F. Bellocci. Ventricular tachycardia in patients with ""idiopathic" mitral valve prolapse: histologic
demostration of associated primary myocardial abnormalities. Latido 1987;12:33.
15.
Abdulla, A. Frustaci, et al. Congenital limphangectasia of the right ventricle. Angiology
1988 (Abstract 35th Cong. of American College of Angiol.).
16.
Frustaci, M. Caldarulo, et al. Cardiac involvement in systemic sclerosis immune-histologic
study and clinical correlation.CHEST August 1988.
17.
Frustaci, M. Caldarulo, et al. Adriamycin myocardiotoxicity: an ultrastructural study and a
pathogenetic hypotesis.CHEST August 1988.
18.
Frustaci, M. Caldarulo, et al. Increased myocardial mastcells and histamine release in
ventricular arrhythmias due to myocarditis; antiarrhythmic effect of H2-antihistamines. CHEST
August 1989 (abstract ACCP Congress)
19.
Frustaci, M. Caldarulo, et al. Adriamycin myocardiotoxicity: an ultrastructural study and a
pathogenetic hypothesis. International Congress of Cardiomyopathies- Florence 1989
20.
Frustaci, M. Caldarulo, et al. Cardiac involvement in systemic sclerosis immune-histologic
study and clinical corralation. International Congress on Cardiomyopathies- Florence 1989
21.
Frustaci, M. Caldarulo, et al. Cardiac biopsy findings in "primary" atrial fibrillation:
Histologic evidence of occult myocardial disease. World Congress of Cardiology- Manila 1990
(accepted for oral comm.)
22.
F Belloci, S. Montenero, A. Nobile, G. Ansalone, A. Frustaci, U. Manzoli. Oral flecainide
for prevention of paroxismal atrial fibrillation: Predictive value of the response to transesophageal
atrial stimulation. JACC (oral presentation at 39th Annual Scientific Session-New Orleans March
1990)
23.
Frustaci, M. Caldarulo, A. Buffon, M. Testa. Small vessel disease as a cause of stable
angina. Biochemical and histologic evidence. XI World Congress of Cardiology- Manila Feb 1990.
24.
Frustaci, M. Caldarulo, A. Buffon, F. Bellocci, U. Manzoli Cardiac biopsy findings in
"primary" atrial fibrillation: histologic evidence of occult myocardial disease. XI World Congress of
Cardiology-Manila Feb 1990.
21
25.
Frustaci, et al. HLA association in the dilated cardiomyopathy.XI World Congress of
Cardiology-Manila Feb 1990.
26.
Bellocci, S. Montenero, A. Nobile, G. Ansalone, A.Frustaci, U. Manzoli. Oral flecainide for
prevention of paroxismal atrial fibrillation: predictive value of the response to transesophageal atrial
stimulation. JACC Vol 15, No 2 Feb 1990:235A
27.
Frustaci, et al. Cardiac biopsy findings in "primary" atrial fibrillation: histologic evidence
of occult myocardial disease. Cardiostim 90-Nizza 20-23 Giu 1990.
28.
Pragliola, A. Frustaci, et al. Hemodynamic behavior and correlations with myocardial
lesions in an experimental model of brain death. Current issues in Thoracic Organ Trasplantation.
Essen, 19-21 Sept 1991.
29.
Melina, F. Colivicchi, G. Melina, A. Frustaci, A. Santoliquido, M. Caldarulo. Silent
myocardial ischemia in asymptomatic diabetic patients with essential hypertension. European Heart
J - supplement August 1991.
30.
Melina, A. Frustaci, et al. Silent myocardial ischemia and ventricular arrhythmias in
asymptomatic diabetic patients with essential hypertension. III International Symposium
"Hypertension associated with diabetes mellitus". Boston USA November 21-23 1991.
31.
Frustaci, M. Caldarulo, N. Magnavita, A. Pietra, E. Sabbioni: Assessment of myocardial
heavy metals content in patients with idiopathic dilated cardiomyopathy. Circulation (abstract)
suppl october 1992.
32.
Nobile, A. Frustaci, P. Zeppilli, A. Spampinato, A. Montenero, P. Zecchi, F. Bellocci.
Idiophatic severe ventricular arrhythmias in young patients: ventricular late potentials as initial
manifestation of organic heart disease. Eur Heart J (abstract) Supplement August 1992.
33.
Frustaci, C. Cellini, F. Bellocci, A. Maseri. Young Survisors of apparently idiopathic
cardiac arrest : results of bi-ventricular endomyocardial biopsy and specific treatment and meadle
term follow-up. Eur. Heart Journal vol.14 ; abstract supplement : August 1993.
34.
Nobile, A. Frustaci, P. Zeppilli, A. Spampinato, S. Montenero, P. Zecchi, F. Bellocci.
Idiophatic severe ventricular arrhythmias in young patients: ventricular late potentials as initial
manifestation of organic heart disease. JACC 1993; 21 :2- (abstract)
35.
Frustaci A, Chimenti C, Di Francesco P, Bellocci F, Russo MA. Results of atrial biopsy in
patients with lone atrial fibrillation. XII International Congress “The New Frontiers of Arrhythmias”
Marilleva 1996; 91-94
36.
Frustaci A, Chimenti C, Morgante E, Russo MA, Maseri A. The histologic substrate of
atrial biopsy in patients with lone atrial fibrillation. Eur Heart J Supplement August 1996
37.
Frustaci A, Chimenti C, Morgante E, Russo MA, Maseri A. The histologic substrate of
atrial biopsy in patients with lone atrial fibrillation. Circulation Supplement November 1996
22
38.
Frustaci A, N. Magnavita, C. Chimenti, M. Caldarulo et al. Marked elevation of myocardial
trace elements in idiopathic dilated cardiomyopathy compared to secondary cardiac
dysfunction. 6th world congress on heart failure mechanisms and management. Geneva May
17-20 1998
39.
Frustaci A, N. Magnavita, C. Chimenti, M. Caldarulo et al. Assessment of myocardial
and muscular trace elements in patients with idiopathic dilated cardiomyopathy and
secondary cardiac dysfunction. American Heart Association 71st Scientific session November
8-11 1998
40.
Frustaci A, C Chimenti, M Setoguchi, S Corsello, M Pieroni, F Crea, A Leri, J kajstura,
P Anversa, A Maseri. Cell Death in Acromegalic cardiomyopathy J Am Coll Cardiol
1999;33:501 A
41.
Frustaci A, C Chimenti, Pieroni M. Prognostic significance of left ventricular aneurysms
with normal global function caused by myocarditis. Eur Heart J Supplement August 1999.
42.
Frustaci A, C Chimenti, Jakoniuk I, A Leri, J kajstura, P Anversa, A Maseri. Type-II
non insulin-dependent diabetes mellitus (NIDDM) and cardiac cell death. Circulation 2000;
102: 3040A.
43.
Chimenti C, Calabrese F, Thiene G, Pieroni M, Maseri A, Frustaci A. Inflammatory left
ventricular microaneurysms as a cause of apparently idiopathic ventricular tachyarrhythmias.
JACC 2001;37 Suppl A:1106A.
44.
Frustaci A, Calabrese F, Chimenti C, Pieroni M, Thiene G, Maseri A. Myocarditis as
lone manifestation of HCV infection: effects of immunosuppressive therapy. Cardiovascular
drugs and Therapy (15) Suppl 1 March 2001.
45.
Chimenti C, Calabrese F, Thiene G, Pieroni M, Maseri A, Frustaci A. Inflammatory left
ventricular microaneurysms as a cause of apparently idiopathic ventricular tachyarrhythmias.
Cardiovascular drugs and Therapy (15) Suppl 1 March 2001
46.
Chimenti C, Calabrese F, Thiene G, Pieroni M, Maseri A, Frustaci A. Inflammatory left
ventricular microaneurysms as a cause of apparently idiopathic ventricular tachyarrhythmias.
Eur Heart J Supplement August 2001
47.
Chimenti C, Pieroni M, Verardo R, Maseri A, Frustaci A. Histologic findings in patients
with clinical and instrumental diagnosis of arrhythmogenic right ventricular dysplasia. JACC
2002;39 Suppl A:135A.
49.
Chimenti C, Pieroni M, Cuoco L, Verardo R, Gentiloni Silveri N, Maseri A, Frustaci A.
Celiac disease associated with autoimmune myocarditis. Congress of the European Society of
Cardiology. Berlin, September 2002.
50.
Chimenti C, Pieroni M, Calabrese F, Verardo R, Thiene G, Maseri A, Frustaci A. Active
Lymphocytic Myocarditis: Virologic and Immunologic Profile of Responders vs Non-Responders
To Immunosuppressive Therapy. Congress of the European Society of Cardiology. Berlin
September 2002.
23
51.
Chimenti C, Pieroni M, Verardo R, Maseri A, Frustaci A. Histologic Findings in Patients
with Clinical and Instrumental Diagnosis of Arrhythmogenic Right Ventricular Dysplasia. Congress
of the European Society of Cardiology. Berlin, September 2002.
52.
Pieroni M, Chimenti C, Verardo R, Maseri A, Frustaci A. Brain Natriuretic Peptide in
Hypertrophic Cardiomyopathy with and without Systolic Dysfunction. Congress of the European
Society of Cardiology. Berlin, September 2002.
53.
Pieroni M, Chimenti C, Calabrese F, Verardo R, Thiene G, Maseri A, Frustaci A. Lone
HCV Myocarditis Responsive to Immunosuppressive Therapy. Congress of the European Society of
Cardiology. Berlin, September 2002.
54.
Chimenti C, Pieroni M, Maseri A, Frustaci A. Histologic findings in patients with clinical
and instrumental diagnosis of sporadic Arrhythmogenic Right Ventricular Dysplasia. Abstract on
American Heart Congress (Circulation 2002).
55.
Chimenti C, Kajstura J, Torella D, Urbanek K, Heleniak H, Colussi C, Di Meglio F, NadalGinard B, Frustaci A, Leri A, Maseri A, Anversa P. Senescence and death of primitive cells and
myocytes leads to premature cardiac aging and heart failure. Abstract on American Heart Congress
(Circulation 2002).
56.
Pieroni M, Chimenti C, Ricci R, Russo MA, Sale P, Maseri A, Frustaci A. Early detection
of Fabry cardiomyopathy by tissue Doppler imaging. Congress of the American College of
Cardiology 2003.
57.
Nanni L, Pieroni M, Chimenti C, Simionati B, Zimbello R, Maseri A, Frustaci A,
Lanfranchi G. Hypertrophic cardiomyopathy: two homozygous cases with "typical" hypertrophic
cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy.
Congress of the European Society of Cardiology. Vienna, September 2003.
58.
Pieroni M, Chimenti C, Bellocci F, Sale P, Russo MA, Maseri A, Frustaci A. Biventricular
histologic findings in patients with Brugada syndrome. Congress of the European Society of
Cardiology. Vienna, September 2003.
59.
Chimenti C, Pieroni M, Russo A, Verardo R, Russo MA, Maseri A, Frustaci A.
Intramyocyte detection of Epstein Barr virus genome by laser capture microdissection in patients
with inflammatory cardiomyopathy. Congress of the American Heart Association November 2003.
60.
Chimenti C, Pieroni M, Antuzzi D, Morgante E, Russo MA, Maseri A, Frustaci A.
Prevalence of Fabry Disease in female patients with hypertrophic cardiomyopathy. Congress of the
American Heart Association November 2003.
61.
Pieroni M, Chimenti C, Bellocci F, Sale P, Russo MA, Maseri A, Frustaci A. Biventricular
histologic findings in patients with Brugada syndrome. Congress of the American Heart Association
November 2003.
24
62.
Chimenti C, Pieroni M, Maurizio Pieroni, Andreina Santagostino, Matteo A Russo, Attilio
Maseri, Andrea Frustaci. Histologic determinants of diastolic dysfunction in patients with Fabry
cardiomyopathy. Congress of the European Society of Cardiology. Munich, September 2004.
63.
Chimenti C, Pieroni M, Russo A, Verardo R, Russo MA, Maseri A, Frustaci A.
Intramyocyte detection of Epstein Barr virus genome by laser capture microdissection in patients
with inflammatory cardiomyopathy. Congress of European Society of Cardiology. Munich,
September 2004.
64.
Pieroni M, Chimenti C, Santagostino A, Maseri A, Corti A, Frustaci A. Myocardial
production and secretion of chromogranin A in hypertrophic cardiomyopathy. 1st biannual meeting
of the Association for European Cardiovascular Pathology. October 21-23, 2004. Padua.
65.
Chimenti C, Pieroni M, Santagostino A, Russo MA, Maseri A, Frustaci A. Histologic
determinants of diastolic dysfunction in patients with Fabry cardiomyopathy.. 1st biannual meeting
of the Association for European Cardiovascular Pathology. October 21-23, 2004. Padua.
66.
Pieroni M, Chimenti C, Santagostino A, Maseri A, Corti A, Frustaci A. Myocardial
production and secretion of chromogranin A in hypertrophic cardiomyopathy. Congress of the
American Heart Association New Orleans, Louisiana, November 2004
67.
Pieroni M, Chimenti C, Santagostino A, Maseri A, Corti A, Frustaci A. Myocardial
production and secretion of chromogranin A in hypertrophic cardiomyopathy. Congress of
European Society of Cardiology, Stockolm, Sweden, September 2005
68.
Pieroni M, Chimenti C, Verardo R, Maseri A, Frustaci A. Brain Natriuretic Peptide in
Hypertrophic Cardiomyopathy with and without Systolic Dysfunction. Congress of European
Society of Cardiology, Stockolm, Sweden, September 2005
69.
Pieroni M , Chimenti C, Nanni L, Belloni E, Lanfranchi G, Frustaci A. Gene expression
profiling in Fabry cardiomyopathy. Dallas, Texas, November 2005
70.
Chimenti C, Pieroni M, Verardo R, Frustaci A. Prevalence of myocardial viral infection in
patients with cardiac syndrome X. Dallas, Texas, November 2005
71.
Chimenti C, Pieroni M, Salvatori L, Morgante E, Sale P, Petrangeli E, Gulino R, MA Russo,
Frustaci A. Cellular mechanisms of cardiac recovery in patients with inflammatory cardiomyopathy
responding to immunosuppressive therapy.
Dallas, Texas, November 2005.
72.
Chimenti C, Hamdani N, Pieroni M, van der Velden J, Stienen GJM, Gaudio C, Paulus WJ,
Frustaci A. Alterations in Myocyte Relaxation and Contraction are the Main Mechanisms of
Cardiac Dysfunction in Fabry Cardiomyopathy. European Congress on Heart Failure, Helsinki,
Finland, July 2006
73.
Chimenti C, Verardo R, Caldarulo M, Russo MA, Frustaci A. Myocarditis in hypertrophic
cardiomyopathy patients presenting acute clinical deterioration. European Congress of Cardiology,
Barcelona, Spain, September 2006.
25
74.
Chimenti C, van der Velden J, Hamdani N, Stienen GJM, Russo MA, Paulus WJ, Frustaci
A, Myofilament Dysfunction in Human Cardiomyocytes with Fabry Disease. American Heart
Association Congress, Chicago, Illinois 2006.
75.
Chimenti C, Tanzilli G, Morgante E, Verardo R, Mangieri E, Gaudio C, Russo MA,
Frustaci A. Fabry‟s Disease: Coronary Small Vessel Obstruction as a Cause of Myocardial
Ischemia and Disease Progression. American Heart Association Congress, Chicago, Illinois 2006.
76.
Chimenti C, Verardo R, Acconcia MC, Caldarulo M, Russo MA, Frustaci A. Myocarditis in
hypertrophic cardiomyopathy patients presenting acute clinical deterioration. Heart Failure
Congress 2007 Hamburg, Germany. Accepted
77.
Chimenti C, Verardo R, Sale P, Russo MA, Frustaci A. Viral infection of intramural
coronary vessels in patients with cardiac Syndrome X. European Congress of Cardiology, Munich,
Germany, September 2008, submitted.
78.
Chimenti C, Morgante E, Tanzilli G, Verardo R, Manieri E, Gaudio C, Russo MA, Frustaci
A. Fabry‟s Disease: Coronary Small Vessel Obstruction as a Cause of Myocardial Ischemia and
Disease Progression. European Congress of Cardiology, Munich, Germany, September 2008,
submitted.
26
COMUNICAZIONI IN CONGRESSI NAZIONALI
1. Frustaci A, Carbone A, Pennestrì F, Mongiardo R, De Santis F, Loperfido F, Coppola E.
Disordine immunitario in corso di fibrosi endomiocardica.Comunicazione Congresso Soc. Ital.
Cardiol. 1982.
2. Pennestrì F, Mongiardo R, Salvatori MP, Comparato C, Digaetano A, Mazzari M, Frustaci A,
Loperfido F. Analisi quantitativa con Eco 2D dell'interessamento calcifico del lembo anteriore in
rapporto alla gravità della stenosi mitralica. Comunicazione XLIII Congr. Soc. Ital. Cardiol. 1982.
3. Maini CL, Schiavoni G, Montenero AS, Soricelli A, Frustaci A, Bonetti M, Mazzari M.
Determinazione non geometrica dei volumi telediastolico e telesistolico in angiocardioscintigrafia.
Comunicazione XLIII Congr. Soc. Ital. Cardiol. 1982.
4. Rebuzzi AG, Schiavoni G, Scabbia E, Frustaci A, Mongiardo R, Spagnolo A. Ipertensione
polmonare primitiva: effetti dell'idralazina, isoproterenolo, nofedipina, fentolamina. Comunicazione
XLIII Congr. Soc. Ital. Cardiol. 1982.
5. Frustaci A, Pennestri F, Mazzari M, Rebuzzi AG, Coppola E, Bellocci F. Cardiomiocitolisi
ipokaliemica. Comunicazione XLIII Congr. Soc. Ital..Cardiol. 1982.
6. Maini CL, Montenero AS, Soricelli A, Frustaci A, Ficola U, Turbati M. Studio della
funzionalità sistilica e della funzionalità diastolica del ventricolo sinistro mediante nuclear
stethoscope. Comunicazione XLIII Congr. Soc.. Ital. Cardiol. 1982
7. Montenero AS, Frustaci A, Mongiardo R, Pennestri F, Turbati M, Marino B, Coppola E.
Sindrome asplenica e polisplenica dell'adulto. Comunicazione XLLL Congr. Soc. Ital. Cardiol. 1982
8. Frustaci A, Bellocci F, Rebuzzi AG, Montenero AS, De Santis F, Dulcimascolo C.
Modificazioni metaboliche cardiache in corso di paralisi ipokaliemica periodica familiare.
Comunicazione XLIV Congr. Soc. Ital. Cardiol. 1983.
9. Montenero AS, Sandric S, Gianolla F, Pavone G, Frustaci A, Comparato C, Turbati M,
Bellocci F. Effetti emodinamici e antiaritmici della mexiletina nella fase acuta dell'infarto
miocardico. Comunicazione XLIV Congr. Soc. Ital. Cardiol. 1983.
10. Biasucci LM, Rebuzzi AG, Mazzari M, Frustaci A, Amico C, Dulcimascolo C, Bosimini E.
Ruolo della frequenza cardiaca nella genesi degli episodi di ischemia miocardica. Comunicazione
XLIV Congr. Soc. Ital. Cardiol. 1983.
11. Frustaci A, Bellocci F, Mazzari M, Rebuzzi AG, Amico CM, Duricchi M. Efficacia dei
betabloccanti nel trattamento delle aritmie ventricolari e sopraventricolari in corso di cardiomiopatia
dilatativa iniziale. Atti XLV Congresso Nazionale della Società Italiana di Cardiologia 1984.
12. Frustaci A, Coppola E, Ferri T, Martuscelli E, Mangeri E, Nigri A. Evoluzione e prognosi della
cardiomiopatia dilatativa: follow-up a tre anni. Comunicazione al XLVI Congresso Nazionale della
Società Italiana di Cardiologia 10-14 Dicembre 1985.
27
13. Frustaci A, Littarru G, Schiavoni G, Pennestrì F, Lucente M, Mazzari M, Rossi E, Ferri T.
Determinazione plasmatica e intramiocardica del Coenzima Q 10 nella cardiomiopatia dilatativa.
Effetti sul ritmo e la contrattilità dopo somministrazione orale. Comunicazione al XLVI Congresso
Nazionale della Società Italiana di Cardiologia dicembre 1985.
14. Frustaci A, Caldarulo M, Rossi E, Coppola E, Manzoli U. Miocardite virale. Valutazione
clinico-istologica al trattamento steroideo ed immunosoppressivo. Comunicazione al XLVII
Congresso Nazionale della Società Italiana di Cardiologia Roma 16-20 dicembre 1986.
15. Frustaci A, Manzoli U. Biopsia endomiocardica del ventricolo dx. Relazione al Simposio su "Il
Ventricolo destro", XLVII Congresso Nazionale della Società italiana di Cardiologia; Roma 16-20
dicembre 1986
16. Mazzari M, Frustaci A, Biasucci LM, Littarru GP, Manzoli U. Il Coenzima Q10 nella
cardiopatia ischemcia. Dati preliminari. Gruppo di studio " Cardiologia Sperimentale" Gardone
Riviera 16-18 aprile 1986.
17. Servidei S, Frustaci A, Sabatelli M, Ricci E, Restuccia D, Di Mauro S, Tonali P.Myopathy and
cardiomyopathy with Glycogen: morphological and biochemical studies of an unusual case. Atti
Congresso Società Nazionale di Neuropatologia. Journal Neurol Sci, luglio 1987.
18. Manzoli U, Schiavoni G, Frustaci A. Utilità e limiti della biopsia endomiocardica nel
laboratorio di emodinamica. Relazione al XLVIII Congresso Nazionale della Società Italiana di
Cardiologia; dicembre 15-19 1987.
19. Greco G, Arcari L, Vegna ML, Frustaci A. Cardiotossicità da antraciclina: decorso e
reversibilità clinica Comunicazione al XLVIII Congresso Nazionale della Società Italiana di
Cardiologia; dicembre 15-19 1987.
20. Frustaci A, Manzoli U. Il microcircolo nelle malattie del muscolo cardiaco. Congresso
Nazionale sul Microcircolo; Fano 1988.
21. Frustaci A. Dispasia adiposa del ventricolo destro. Diagnosi differenziale con le cardiomiopatie
primitive di tipo dilatativo. Relazione al XLIX Congr. Nazionale Soc. Ital. Cardiol. Dic. 1988
22. Frustaci, Caldarulo M, Buffon A, Trani C, Gentiloni N. Patterns istomorfologici inusuali di
amiloidosi cardiaca. Giornate Cardiologiche Romane- Roma 19-2 Apr 1990
23. Zeppilli P., Frustaci A., Merlino B., Bellocci F. Aritmie ventricolari e miocardite in atleti:
un'associazione da non dimenticare. Congresso Nazionale Medicina dello Sport - Roma 1991.
24. Santarelli P, Frustaci A, Sgadari A, Di Gennaro M, Alessandrini F, Natale A, Pisanò E,
Biscione F, Carbonin PU, Possati GF. Caratteristiche istologiche e proprietà meccaniche del tessuto
atriale in pazienti con sindrome di Wolff- Parkinson- White. Cardiologia - vol.36 suppl 2 al n12 Dicembre 1991.
25. Melina S, Frustaci A, et al. Ipertensione arteriosa e infarto del miocardio nell'anziano diabetico.
XCII Congresso Nazionale della Società Italiana di Medicina Interna. Roma 15-19 Ottobre 1991.
28
26. Melina S, Frustaci A, et al. Modificazioni della pressione arteriosa e dei tempi sistolici del
ventricolo sinistro dopo sforzo isometrico in figli di ipertesi con e senza diabete mellito XCII
Congresso Nazionale della Società Italiana di Medicina Interna. Roma 15-19 Ottobre 1991.
27. Frustaci A. Relazione "Cardiomiopatia dilatativa reversibile da carenza di GH" Congresso
Internazionale "GH oggi:non solo crescita" Roma 31 Gen - 1 Feb 1992.
28. Frustaci A., Chimenti C., Bellocci F., Morgante E., Russo M.A., Maseri A. Biopsia miocardica
atriale in pazienti con fibrillazione atriale isolata. Congresso Nazionale della Associazione Medici
Cardiologi Ospedalieri 1997
29. Frustaci A., Chimenti C., Bellocci F., Morgante E., Russo M.A., Maseri A. Biopsia miocardica
atriale in pazienti con fibrillazione atriale isolata. LVII Congresso Nazionale della Società Italiana
di Cardiologia 1996
30. Chimenti C., Frustaci A., Pieroni M., Maseri A. Una disfunzione cardiaca biventricolare in
pazienti con coronaropatia asintomatica puo‟ essere causata da una miocardite piuttosto che
da ischemia miocardica. LIX Congresso Nazionale della Società Italiana di Cardiologia 1998
31. Chimenti C, Pieroni M, Bellocci F, Frustaci A. Aneurismi infiammatori localizzati del
ventricolo sinistro come causa di aritmie ventricolari a cuore apparentemente sano. LXI
Congresso Nazionale della Società Italiana di Cardiologia 2000
32. Chimenti C, Pieroni M, Calabrese F, Thiene G, Maseri A, Frustaci A. Miocardite come
unica manifestazione di infezione da hcv sensibile al trattamento immunosoppressivo LXII
Congresso Nazionale della Società Italiana di Cardiologia 2001.
33. Pieroni M, Chimenti C, Maseri A, Frustaci A. Correlazione tra livelli plasmatici di brain
natriuretic peptide e fase dilatativa nella cardiomiopatia ipertrofica. LXII Congresso
Nazionale della Società Italiana di Cardiologia 2001.
34. Pieroni M, Chimenti C, Ricci R, Sale P, Russo MA, Maseri A, Frustaci A. Diagnosi precoce
di coinvolgimento cardiaco nella malattia di Fabry attraverso il Doppler tissutale. LXIII
Congresso Nazionale della Società Italiana di Cardiologia 2002.
35. Pieroni M, Chimenti C, Bellocci F, Sale P, Russo MA, Maseri A, Frustaci A. Biventricular
histologic findings in patients with Brugada syndrome. LXIV Congresso Nazionale della
Società Italiana di Cardiologia 2003.
36. Pieroni M, Chimenti C, Santagostino A, Maseri A, Corti A, Frustaci A. Myocardial
production and secretion of chromogranin A in hypertrophic cardiomyopathy. LXV
Congresso Nazionale della Società Italiana di Cardiologia 2004
37. Chimenti C, Pieroni M, Santagostino A, Verardo R, Maseri A, Frustaci A. Histologic
Findings in Patients with Clinical and Instrumental Diagnosis of Arrhythmogenic Right
Ventricular Dysplasia. LXV Congresso Nazionale della Società Italiana di Cardiologia 2004.
29
CAPITOLI IN LIBRI
1. Frustaci A, Manzoli U, Lippa S, Oradei A, Littarru GP and Folkers K. Blood and myocardial
levels of Ubiquinone in dilated cardiomyopathy: a biochemical approach to Co Q 10 therapy.
In: "Biomedical and clinical aspects of coenzime Q"; K. Folkers and Y. Yamamura Editors.
Elsevier publisher 1986 pag.157-164.
2. Frustaci A, Bellocci F, Manzoli U. Usefulness of endomyocardial biopsy in brady and
tachyarrhythmias. Etiopathogenetic definition.
In: "Progress in Clinical Pacing" edited by M. Santini , M. Pistolese, A. Alliegro, Rome 1986 pg
187-191.
3. Fenici RR, Ruggieri MP, Frustaci A. Le indagini invasive in cardiologia dello sport: nozioni
generali e loro utilità.
In: Cardiologia dello Sport (Paolo Zeppilli) 1995.
4. Zeppilli P, Santini C, Frustaci A. Cardiomiopatie, miocarditi e pericarditi in cardiologia dello
sport.
In: Cardiologia dello Sport (Paolo Zeppilli) 1995.
5. Frustaci A, Chimenti C, Zeppilli P. Terapia nelle malattie del sistema cardiovascolare.
In: Terapia medico-chirurgica. D. Gui, M Azzaretto. 2000 pag 193-262.
In fede
ANDREA FRUSTACI
30